Abacavir is an antiviral medication used in combination with other antiretroviral drugs for the treatment of HIV-1 infection.
Adverse reactions or quality problems experienced with the use of this product may be reported to the FDA's MedWatch Adverse Event Reporting program using the contact information at the bottom of this page.
FDA Drug Safety Communication: Safety Review update of Abacavir and possible increased risk of heart attack
Information for Healthcare Professionals: Abacavir (marketed as Ziagen) and Abacavir-Containing Medications[ARCHIVED]
FDA Alert (7/24/2008)
Early Communication about an Ongoing Safety Review of Ziagen (Abacavir) and Videx (Didanosine)[ARCHIVED]